您的位置: 首页 > 农业专利 > 详情页

FUSED PENTACYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY
专利权人:
SANOFI;UCB BIOPHARMA SPRL
发明人:
XUAN, Mengyang,FORICHER, Yann,DE HARO GARCIA, Teresa,JOHNSON, James Andrew,ZHU, Zhaoning,HORSLEY, Helen Tracey,MACCOSS, Malcolm,HUTCHINGS, Martin Clive,BROOKINGS, Daniel Christopher
申请号:
CR20190526
公开号:
CR20190526A
申请日:
2018.04.24
申请国别(地区):
CR
年份:
2020
代理人:
摘要:
A formula compound (I) or a pharmaceutically acceptable salt defined in the explanatory report, as a powerful modulator of human TNFa activity, is therefore beneficial to the treatment and / or prevention of various human diseases, Including self immunity and inflammation; neurodegenerative disorders; pain and harmful disorders; cardiovascular disorders; metabolic disorders; eye disorders; and tumor disorders, such as formula (I) deficiency or acceptable salinization, Being potent modulators of human TNFA activity,Are accordingly of benefit in the treatment and/or prevention of various human ailments,including autimmune and inflammatory disorders;neurological and neurgenerative disorders;pain and discipptive disorders;cardiovascular disorders;metabolic disorders;obligo disorders;and oncological disorders.Un compuesto de fórmula (I) como se define en la memoria descriptiva, o una sal farmacéuticamente aceptable del mismo, como moduladores potentes de la actividad de TNFa humano, los cuales por consiguiente son beneficiosos para el tratamiento y/o la prevención de diversas enfermedades humanas, incluyendo trastornos autoinmunológicos e inflamatorios; trastornos neurológicos y neurodegenerativos; dolor y trastornos nociceptivos; trastornos cardiovasculares; trastornos metabólicos; trastornos oculares; y trastornos oncológicos.A compound of formula (I) as defined herein, or a pharmaceutically acceptable salt thereof, being potent modulators of human TNFa activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充